Why People with Cancer Should Be in COVID-19 Vaccination Trials
Since the COVID-19 vaccine clinical trials began, people being treated for cancer and those who have survived the disease have been largely excluded.
“We’ve learned that patients with cancer are especially vulnerable to severe illness, hospitalization, or death due to COVID-19,” Dr. Everett E. Vokes, president of ASCO, said in the joint statement..
“However, since clinical trials for COVID-19 vaccines have largely excluded patients with cancer, we still have a long way to go to better understand how safe and effective COVID-19 vaccines are for patients in active treatment,” he added.